CD8A and neoplasm: In the meantime, DC maturation caused by iNKT cells leads to conversion from tolerogenic to immunogenic adaptive immune responses, boosting downstream tumor-specific CD4+ or CD8+ T cell responses, and might potentially be exploited in adjuvant approaches for immunotherapy.